StockData
Atrium Therapeutics, Inc. logo

Atrium Therapeutics, Inc. (RNA) stock

RNANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026
$6.48+0.05 (+0.78%)

Close on Nov 17, 2026Market cap $110.85MP/E –Yield –

Atrium Therapeutics total assets

Total assets on the balance sheet at the end of each period.

Atrium Therapeutics's total assets was $263.99M at Sep 30, 2026. For fiscal 2025 it was $8.35M.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$8.35M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$263.99M–
Q2 FY2026Jun 30, 2026$280.51M–
Q1 FY2026Mar 31, 2026$292.36M–
Q4 FY2025Dec 31, 2025$8.35M–

More Atrium Therapeutics figures

See a number that looks wrong?